Combined evaluation of Fibrosis‐4 index and fatty liver for stratifying the risk for diabetes mellitus-Reference-Cited by-同舟云学术

Combined evaluation of Fibrosis‐4 index and fatty liver for stratifying the risk for diabetes mellitus

Published:2022-05-05 Issue:9 Volume:13 Page:1577-1584
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J of Diabetes Invest

Author:

Todo Yasuhiko¹,Miyake Teruki²^ORCID,Furukawa Shinya³,Matsuura Bunzo⁴,Ishihara Toru²⁵,Miyazaki Masumi²,Shiomi Akihito¹,Nakaguchi Hironobu³,Kanzaki Sayaka²,Yamamoto Yasunori²,Koizumi Yohei²,Yoshida Osamu²,Tokumoto Yoshio²,Hirooka Masashi²,Takeshita Eiji²,Kumagi Teru⁶,Ikeda Yoshio²,Abe Masanori²,Iwata Takeru⁵,Hiasa Yoichi²^ORCID

Affiliation:

1. Department of Diabetes and Endocrinology Uwajima City Hospital Uwajima Japan

2. Department of Gastroenterology and Metabology Ehime University Graduate School of Medicine Toon Japan

3. Health Services Center Ehime University, Bunkyo Matsuyama Japan

4. Department of Lifestyle‐Related Medicine and Endocrinology Ehime University Graduate School of Medicine Toon Japan

5. Ehime General Health Care Association Matsuyama Japan

6. Postgraduate Medical Education Center Ehime University Graduate School of Medicine Toon Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject